Ligand Pharmaceuticals Inc (LGND)
114.58
+0.64
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
115.00
+0.42
(+0.37%)
After-Hours: 20:00
Ligand Pharmaceuticals Total Assets (Quarterly): 954.87M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cellectar Biosciences Inc | 37.29M |
| Revance Therapeutics Inc | 461.56M |
| Pieris Pharmaceuticals Inc | 20.52M |
| Zymeworks Inc | 487.15M |
| CNS Pharmaceuticals Inc | 7.409M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 113.69M |
| Shareholders Equity (Quarterly) | 841.18M |
| Current Ratio | 12.49 |